This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Cancer is a group of diseases characterized by uncontrolled growth of cells in the body.
Th ese lesions, if not treated, grow until they become life-threatening or fatal. Traditionally,
surgery has been the main form of tumor control, though this is not performed where the growth
is deep-seated in the body or located at a site where surgery could itself be life-threatening.
Alternatives to, or assisting surgery are chemotherapy and radiotherapy. However, these two
traditional forms of cancer therapy suff er due to harmful eff ects to the healthy parts of the body.
To address this, there is a global push to fi nd compounds that are eff ective against neoplastic
cells, but less harmful against normal healthy cells of the body. Complementing this is the search
for in vitro or in vivo assays that are more indicative of antitumor activity. Finally, there has
been a growing push to fi nd better drug delivery systems capable of more selective delivery
of drugs to tumors in the body. Th is presentation discusses some of the cell-based assays and
small animal models set up by our labs in the past decade, drug delivery systems we have tested
so far, and biologicals (protein, nucleic acid, polysaccharide) trialed so far, some of which are
undergoing clinical testing
Crispin R. Dass has 17 years of cell and molecular biology research experience, mainly focusing on oncological
R&D. His research is on systems at various levels ? in silico, in vitro, in vivo, ADME/Tox, clinical, and also
with biomedical education. He has worked on projects for Johnson & Johnson, GlaxoSmithKline, Amgen,
and Novartis. His extensive experience is documented in his 120 papers to date, with publications in Nature
Medicine, Journal of the National Cancer Institute, Biomaterials, Nucleic Acids Research, Cancer, and Journal
of Controlled Release. He is currently on the editorial board of 3 other journals in his fi eld, and has been invited
to chair sessions and to give plenary lectures at national and international conferences. Based currently in St
Albans (Melbourne, Australia), he has research links with Thailand, Fiji, USA, China, South Korea, Japan, Iran
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals